Sontuzumab (AS1402), a humanized IgG1kappa monoclonal antibody targeting MUC1, exhibits high affinity, with a dissociation constant (Kd) of approximately 1 nM for the extracellular peptide sequence PDTR of MUC1. It is utilized in breast cancer research [1].
CAS Number:
[372075-37-1]
Target:
AS1402 , huHMFG-1
* VAT and and shipping costs not included. Errors and price changes excepted
